微小病毒
无菌性脑膜炎
医学
肠道病毒
回声病毒
脑膜炎
脑炎
心肌炎
生物
病毒
病毒学
柯萨奇病毒
免疫学
儿科
内科学
生物化学
基因
核糖核酸
作者
Burk Jubelt,Howard L. Lipton
出处
期刊:Handbook of Clinical Neurology
[Elsevier BV]
日期:2014-01-01
卷期号:123: 379-416
被引量:96
标识
DOI:10.1016/b978-0-444-53488-0.00018-3
摘要
Abstract The human enteroviruses (EV) comprise one group of the picornavirus family. The best known members are the polioviruses (PV), coxsackieviruses, and echoviruses. They replicate in the oropharynx and gastrointestinal (GI) tract and are primarily spread by fecal-hand-oral contamination. With systemic invasion nonspecific febrile illness occurs as well as specific syndromes (rashes, hand-foot-and-mouth disease, herpangina, pleurodynia, myocarditis/pericarditis, and conjunctivitis). With systemic replication a high level viremia may result in central nervous system (CNS) invasion. EV activity can be endemic in warm climates or epidemic in temperate climates. In temperate climates, because of improved hygiene, newborns were not exposed to EV until they were older, resulting in large epidemics of poliomyelitis, which were finally curtailed with the killed PV vaccines in the 1950s and the live oral PV vaccines in the 1960s. Today, “aseptic” meningitis is the most common neurologic syndrome caused by EV. EV are also the most common cause of viral meningitis. Other EV neurologic syndromes include encephalitis, paralytic disease, persistent infections, and the severe group B coxsackievirus fatal systemic infections of neonates. Newly recognized emerging infections include EV71 rhombencephalitis/brainstem encephalitis and saffold virus (Saf V) meningitis and cerebellitis. Diagnostic clues can come from epidemics, systemic manifestations, household infections, the cerebrospinal fluid picture, and the neurologic syndromes. However, definite diagnosis depends on laboratory methods, primarily nucleic acid amplification. Treatment of acute infections is supportive. Preventive methods include good hygiene and aggressive polio vaccination programs.
科研通智能强力驱动
Strongly Powered by AbleSci AI